Michael Scheurlen

2.1k total citations
46 papers, 1.4k citations indexed

About

Michael Scheurlen is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Michael Scheurlen has authored 46 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 13 papers in Hepatology and 10 papers in Molecular Biology. Recurrent topics in Michael Scheurlen's work include Hepatitis C virus research (10 papers), Neuroendocrine Tumor Research Advances (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). Michael Scheurlen is often cited by papers focused on Hepatitis C virus research (10 papers), Neuroendocrine Tumor Research Advances (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). Michael Scheurlen collaborates with scholars based in Germany, United States and Hungary. Michael Scheurlen's co-authors include Michael R. Kraus, Hubert Mörk, Hermann Faller, Herbert Csef, Arne Schäfer, Oliver Al‐Taie, Arne Schäfer, Josef Köhrle, Paul M. Weber and Franz Jakob and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Hepatology.

In The Last Decade

Michael Scheurlen

43 papers receiving 1.4k citations

Peers

Countries citing papers authored by Michael Scheurlen

Since Specialization

Citations

This map shows the geographic impact of Michael Scheurlen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Scheurlen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Scheurlen more than expected).

Fields of papers citing papers by Michael Scheurlen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Scheurlen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Scheurlen. The network helps show where Michael Scheurlen may publish in the future.

Co-authorship network of co-authors of Michael Scheurlen

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Scheurlen. A scholar is included among the top collaborators of Michael Scheurlen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Scheurlen. Michael Scheurlen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Use of Gene Expression Analysis for Discrimination of Primary and Secondary Adenocarcinoma of the Liver 2018 ·Oncology ·Holger G. Hass, Ulrich Vogel, Michael Scheurlen, Jürgen Jobst	5
2	Gene-expression Analysis Identifies Specific Patterns of Dysregulated Molecular Pathways and Genetic Subgroups of Human Hepatocellular Carcinoma 2016 ·Anticancer Research ·Holger G. Hass, Ulrich Vogel, Michael Scheurlen, Jürgen Jobst	30
3	Overexpression of Tumor-Associated Trypsin Inhibitor (SPINK1/TATI) in Hepatitis C-Associated Hepatocellular Carcinoma: Potential Implications for Viral Hepatocarcinogenesis 2014 ·Oncology Research and Treatment ·Holger G. Hass, Jürgen Jobst, Ulrich Vogel, Michael Scheurlen, Oliver Nehls	11
4	Improvement of Neurocognitive Function in Responders to an Antiviral Therapy for Chronic Hepatitis C 2013 ·Hepatology ·Michael R. Kraus, Arne Schäfer, G Teuber, H. Porst, Kathrin Sprinzl, (unknown), Christian Keicher, Michael Scheurlen	38
5	Complete Pathological Remission of Locally Advanced, Unresectable Pancreatic Cancer (LAPC) after Intensified Neoadjuvant Chemotherapy 2013 ·Oncology Research and Treatment ·Ingo Hartlapp, Justus Müller, W. Kenn, Ulrich Steger, Christoph Isbert, Michael Scheurlen, Christoph‐Thomas Germer, (unknown), Volker Kunzmann	16
6	Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression 2009 ·Journal of Hepatology ·Arne Schäfer, Michael Scheurlen, Jochen Seufert, Christian Keicher, Benedikt Weißbrich, Peter Rieger, Michael R. Kraus	27
7	Differential effects of PPARγ activation by the oral antidiabetic agent pioglitazone in Barrett’s carcinoma in vitro and in vivo 2009 ·Journal of Gastroenterology ·Oliver Al‐Taie, (unknown), Bertram Illert, Tiemo Katzenberger, Hubert Mörk, Michael R. Kraus, Hans Barthelmes, Michael Scheurlen, Jochen Seufert	12
8	Deterioration of health-related quality of life and fatigue in patients with chronic hepatitis C: Association with demographic factors, inflammatory activity, and degree of fibrosis 2008 ·Journal of Hepatology ·G Teuber, Arne Schäfer, (unknown), Kathrin Paul, Christian Keicher, Michael Scheurlen, Stefan Zeuzem, Michael R. Kraus	44
9	Sustained Virological Response in the Antiviral Therapy of Chronic Hepatitis C: Is There a Predictive Value of Interferon-Induced Depression? 2007 ·Chemotherapy ·Arne Schäfer, Michael Scheurlen, Benedikt Weißbrich, (unknown), Michael R. Kraus	13
10	High recurrence rate of Barrett's epithelium during long-term follow-up after argon plasma coagulation 2006 ·Scandinavian Journal of Gastroenterology ·Hubert Mörk, Oliver Al‐Taie, (unknown), Michael R. Kraus, Michael Scheurlen	25
11	Psychiatric Symptoms in Patients With Chronic Hepatitis C Receiving Interferon Alfa-2b Therapy 2003 ·The Journal of Clinical Psychiatry ·Michael R. Kraus, Arne Schäfer, Hermann Faller, Herbert Csef, Michael Scheurlen	183
12	Glutathione peroxidase isoforms as part of the local antioxidative defense system in normal and Barrett's esophagus 2003 ·International Journal of Cancer ·Hubert Mörk, Michael Scheurlen, Oliver Al‐Taie, (unknown), Michael R. Kraus, (unknown), Franz Jakob, Josef Köhrle	47
13	Compliance with Therapy in Patients with Chronic Hepatitis C: Associations with Psychiatric Symptoms, Interpersonal Problems, and Mode of Acquisition 2001 ·Digestive Diseases and Sciences ·Michael R. Kraus, Arne Schäfer, Herbert Csef, Hermann Faller, Hubert Mörk, Michael Scheurlen	62
14	Inverse mRNA Expression of the Selenocysteine-Containing Proteins GI-GPx and SeP in Colorectal Adenomas Compared With Adjacent Normal Mucosa 2000 ·Nutrition and Cancer ·Hubert Mörk, (unknown), (unknown), (unknown), (unknown), Michael Scheurlen, (unknown), Josef Köhrle	55
15	Emotional State, Coping Styles, and Somatic Variables in Patients With Chronic Hepatitis C 2000 ·Psychosomatics ·Michael R. Kraus, Arne Schäfer, Herbert Csef, Michael Scheurlen, Hermann Faller	100
16	Cavernous transformation of the portal vein associated with common bile duct strictures: report of two cases 1998 ·Gastrointestinal Endoscopy ·Hubert Mörk, Paul M. Weber, (unknown), (unknown), Michael Scheurlen	28
17	Application of Monte Carlo simulation for three-dimensional flows 1992 ·In AGARD ·Michael Scheurlen, Berthold Noll, S. Wittig	2
18	Hypereosinophilic Syndrome Resembling Chronic Inflammatory Bowel Disease with Primary Sclerosing Cholangitis 1992 ·Journal of Clinical Gastroenterology ·Michael Scheurlen, Hubert Mörk, (unknown)	45
19	In vivo validation of image‐directed doppler measurement of superior mesenteric artery blood flow 1992 ·Journal of Clinical Ultrasound ·Michael Scheurlen, Cornelius F. Waller, Franz Hartmann	12
20	Microbic Superinfection in Relapse of Inflammatory Bowel Disease 1992 ·Journal of Clinical Gastroenterology ·Paul M. Weber, Matthias Koch, W. R. Heizmann, Michael Scheurlen, H Jenss, Franz Hartmann	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact